- Report
- October 2023
- 178 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- October 2023
- 177 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- October 2023
- 188 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- October 2023
- 190 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- October 2023
- 183 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- August 2023
- 173 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- March 2024
- 163 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Drug Pipelines
- April 2024
- 398 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- November 2023
- 175 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- April 2024
- 115 Pages
Global
From €4300EUR$4,500USD£3,659GBP
- Report
- May 2024
- 200 Pages
Global
From €3966EUR$4,150USD£3,374GBP
- Report
- February 2024
- 114 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- January 2024
- 130 Pages
Global
From €4300EUR$4,500USD£3,659GBP
- Report
- September 2023
- 115 Pages
Global
From €4300EUR$4,500USD£3,659GBP
- Report
- May 2023
- 120 Pages
Global
From €4300EUR$4,500USD£3,659GBP
- Report
- December 2023
- 140 Pages
Global
From €4253EUR$4,450USD£3,618GBP
- Report
- July 2023
- 145 Pages
Global
From €3010EUR$3,150USD£2,561GBP
- Report
- May 2024
- 200 Pages
Global
From €3966EUR$4,150USD£3,374GBP
- Report
- May 2024
- 200 Pages
Global
From €3966EUR$4,150USD£3,374GBP
Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more